The rating is based on a number of factors, including TMC’s unique role in coordinating capital investment, initiatives and services on a large medical complex.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that TMC will continue to generate strong cash flow even as it funds the formation of five research institutes.
More articles on healthcare finance:
For-profit hospital stock report: Week of Sept. 12-16
15 healthcare CFOs in the headlines
Henry Ford closes on $1B bond sale
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
